Peter van Ruitenbeek
Biographic Data
| ID | 7372644 |
|---|---|
| NAME | Peter van Ruitenbeek |
| GIVEN NAMES | Peter |
| FAMILY NAME | van Ruitenbeek |
| SIGNATURE | VAN RUITENBEEK P |
| AFFILIATIONS | Maastricht University |
| ORCID | 0000-0002-3802-6551 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Methylphenidate as a treatment option for substance use disorder
A transition in viewing mental disorders from conditions defined as a set of unique characteristics to one of the quantitative variations on a collection of dimensions allows overlap between disorders. The overlap can be utilized to extend to treatment approaches. Here, we consider the overlap between attention-deficit/hyperactivity disorder and substance use disorder to probe the suitability to use methylphenidate as a treatment for substance us…
Cannabis Use and Neuroadaptation
Currently, the assessment of the neurobehavioral consequences of repeated cannabis use is restricted to studies in which brain function of chronic cannabis users is compared to that of non-cannabis using controls. The assumption of such studies is that changes in brain function of chronic users are caused by repeated and prolonged exposure to acute cannabis intoxication. However, differences in brain function between chronic cannabis users and no…
No prominent works on this page.
Cannabis Use and Neuroadaptation
Currently, the assessment of the neurobehavioral consequences of repeated cannabis use is restricted to studies in which brain function of chronic cannabis users is compared to that of non-cannabis using controls. The assumption of such studies is that changes in brain function of chronic users are caused by repeated and prolonged exposure to acute cannabis intoxication. However, differences in brain function between chronic cannabis users and no…
Methylphenidate as a treatment option for substance use disorder
A transition in viewing mental disorders from conditions defined as a set of unique characteristics to one of the quantitative variations on a collection of dimensions allows overlap between disorders. The overlap can be utilized to extend to treatment approaches. Here, we consider the overlap between attention-deficit/hyperactivity disorder and substance use disorder to probe the suitability to use methylphenidate as a treatment for substance us…
Cognition (2 works) · Medicine (2 works) · Neurotransmitter Receptor Influence on Behavior (2 works) · Psychiatry (2 works) · Psychology (2 works) · Attention Deficit Hyperactivity Disorder (1 work) · Cannabidiol (1 work) · Cannabinoid (1 work) · Cannabis (1 work) · Cannabis and Cannabinoid Research (1 work)